Research Article
BibTex RIS Cite

Kronik obstruktif akciğer hastalığı alevlenmesinde taburculuk kararı verilmesinde laktat klirensinin rolü: Retrospektif kohort çalışma

Year 2018, , 96 - 98, 01.05.2018
https://doi.org/10.28982/josam.409615

Abstract

Amaç: Kalabalık acil servislerde kronik obstruktif akciğer hastalığı (KOAH) alevlenmesi ile başvuran hastalar sıklıkla semptomatik tedavi ile taburcu edilmektedir. Bu durum hastaların hastaneye başvuru ve atak sayısını arttırmaktadır. Başvuru anında bakılacak ucuz ve kolay kan parametreleri ile yatış öngörüsü yapabilmek oldukça önemlidir. Bizde çalışmamızda, acil servise KOAH akut alevlenmesi ile başvuran hastalarda, yatış veya taburculuk kararı verilmesi ile laktat klirensi arasındaki ilişkiyi araştırmayı amaçladık. 

Yöntemler: Bu çalışmada, 1 Ocak 2014 ile 1 Ocak 2018 tarihleri arasında Batman Bölge Devlet Hastanesi Acil Servisi'ne KOAH atak nedeniyle başvuran 18 yaş üstü hastalar retrospektif olarak incelendi. Hastalar 2 gruba ayrıldı. Grup 1, acil olarak tedaviden sonra taburcu olan hastaları, grup 2'yi hastaneye yatırılan hastaları kapsamaktadır. Her iki grup laktat klirens değerleri açısından karşılaştırıldı.

Bulgular: Çalışmaya 117 hasta dahil edildi. Bunlardan 65'i taburcu olurken; 52'si hastaneye yatırıldı. Hastanede yatan hastalardan 6’sı yoğun bakım ünitesine yatırıldı. Hastaların 41’i kadın, 76’sı erkek idi. Başvuran ve taburcu edilen hastaların ilk ve son laktat değerleri arasında bir fark bulamadık (p=0,345 ve 0,829). Bununla birlikte, taburcu olan hastaların laktat açıklıkları daha yüksek iken, hastaneye yatırılan hastaların laktat klirensi daha düşük bulundu (p<0,001).

Sonuç: KOAH atak nedeni ile acil servise başvuran hastalarda taburculuk veya yatış kararı vermede, laktat klirensinin, bir belirteç olarak kullanılabileceğini düşünmekteyiz.

References

  • 1. Celi BR, MacNee W. Standarts for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004;23:932-46.
  • 2. Chapman KR, Mannino DM, Soriano JB, et al. Epidemiology and cost of chronic obstructive pulmonary disease. Eur Respir J. 2006;27:188-207.
  • 3. Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J. 2009;33(5):1165-85.
  • 4. Tan WC, Lo C, Jong A ve ark. Marijuana and chronic obstructive lung disease: a population-based study. CMAJ. 2009;180:814-820.
  • 5. Hospers JJ, Postma DS, Rijcken B, Weiss ST, Schouten JP. Histamine airway hyperresponsiveness and mortality from chronic obstructive pulmonary disease: a cohort study. Lancet. 2000;356:1313-7.
  • 6. Wedzicha JA, Seemungal TA. COPD exacerbations: defining their cause and prevention. Lancet. 2007;370:786-96.
  • 7. Seemungal TA, Donaldson GC, Paul EA, Bestall JC, Jeffries DJ, Wedzicha JA. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;157:1418-22.
  • 8. Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017 Report. Web site: www.goldcopd.org
  • 9. Brooks GA. Lactate shuttles in nature. Biochem Soc Trans. 2002;30:258-264.
  • 10. Philp A, Macdonald AL, Watt PW. Lactate-A signal coordinating cell and systemic function. J Exp Biol. 2005;208:4561-75.
  • 11. Vernon C, Letourneau JL. Lactic acidosis: Recognition, kinetics, and associated prognosis. Crit Care Clin. 2010;26:255-83.
  • 12. Levy B, Sadoune LO, Gelot AM, Bollaert PE, Nabet P, Larcan A. Evolution of lactate/pyruvate and arterial ketone body ratios in the early course of catecholamine-treated septic shock. Crit Care Med. 2000;28:114-9.
  • 13. Revelly JP, Tappy L, Martinez A, et al. Lactate and glucose metabolism in severe sepsis and cardiogenic shock. Crit Care Med. 2005;33:2235–40.
  • 14. Zhang Z, Xu X. Lactate clearance is a useful biomarker for the prediction of all-cause mortality in critically ill patients: a systematic review and meta-analysis. Crit Care Med. 2014;42:2118-25.
  • 15. Bernardin G, Pradier C, Tiger F, Deloffre P, Mattei M. Blood pressure and arterial lactate level are early indicators of short-term survival in human septic shock. Intensive Care Med. 1996;22:17–25.
  • 16. Nguyen HB, Rivers EP, Knoblich BP, et al. Early lactate clearance is associated with improved outcome in severe sepsis and septic shock. Critical Care Med. 2004;32:1637-42.
  • 17. Cain SM. Oxygen delivery and uptake in dogs during anemic and hypoxic hypoxia. J Appl Physiol Respir Environ Exerc Physiol. 1977;42:228-34.

The role of lactate clearance on deciding discharge in exacerbation of chronic obstructive pulmonary disease: Retrospective cohort study

Year 2018, , 96 - 98, 01.05.2018
https://doi.org/10.28982/josam.409615

Abstract

Aim: Patients presenting with chronic obstructive pulmonary disease (COPD) exacerbation in crowded emergency departments are often discharged with symptomatic treatment. This situation increases the number of patients admitted to the hospital and the number of attacks. It is very important to be able to predict hospitalization with cheap and easy blood parameters to be looked at the time of application. In our study, we aimed to investigate the relationship between lactate Clearance and admission or discharge decision in patients presenting with acute exacerbation of COPD.

Methods: In this study, patients over 18 years old who were admitted to Batman Regional State Hospital Emergency Department with COPD attack between January 1, 2014 and January 1, 2018 were retrospectively studied. The patients were divided into 2 groups. Group 1 included the patients who discharged after treatment in emergency, group 2 included the patients who hospitalized. Both groups were compared in terms of lactate clearance values.

Results: We studied 117 patients who met the criteria for inclusion in the study. Of these, 65 were discharged and 52 were hospitalized. Six of the hospitalized patients were hospitalized in the intensive care unit. Forty-one patients were female and 76 were male.  We did not find any difference between the first and last lactate values of patients who were admitted and discharged (p=0.345 and 0.829). However, the lactate clearances of the discharged patients were higher, while the lactate clearances of patients with hospitalization indications were lower (p<0.001).

Conclusion: We think that lactate clearance can be used as a marker in patients presenting emergency services with COPD exacerbation without deciding on discharge or admission.

References

  • 1. Celi BR, MacNee W. Standarts for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004;23:932-46.
  • 2. Chapman KR, Mannino DM, Soriano JB, et al. Epidemiology and cost of chronic obstructive pulmonary disease. Eur Respir J. 2006;27:188-207.
  • 3. Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J. 2009;33(5):1165-85.
  • 4. Tan WC, Lo C, Jong A ve ark. Marijuana and chronic obstructive lung disease: a population-based study. CMAJ. 2009;180:814-820.
  • 5. Hospers JJ, Postma DS, Rijcken B, Weiss ST, Schouten JP. Histamine airway hyperresponsiveness and mortality from chronic obstructive pulmonary disease: a cohort study. Lancet. 2000;356:1313-7.
  • 6. Wedzicha JA, Seemungal TA. COPD exacerbations: defining their cause and prevention. Lancet. 2007;370:786-96.
  • 7. Seemungal TA, Donaldson GC, Paul EA, Bestall JC, Jeffries DJ, Wedzicha JA. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;157:1418-22.
  • 8. Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017 Report. Web site: www.goldcopd.org
  • 9. Brooks GA. Lactate shuttles in nature. Biochem Soc Trans. 2002;30:258-264.
  • 10. Philp A, Macdonald AL, Watt PW. Lactate-A signal coordinating cell and systemic function. J Exp Biol. 2005;208:4561-75.
  • 11. Vernon C, Letourneau JL. Lactic acidosis: Recognition, kinetics, and associated prognosis. Crit Care Clin. 2010;26:255-83.
  • 12. Levy B, Sadoune LO, Gelot AM, Bollaert PE, Nabet P, Larcan A. Evolution of lactate/pyruvate and arterial ketone body ratios in the early course of catecholamine-treated septic shock. Crit Care Med. 2000;28:114-9.
  • 13. Revelly JP, Tappy L, Martinez A, et al. Lactate and glucose metabolism in severe sepsis and cardiogenic shock. Crit Care Med. 2005;33:2235–40.
  • 14. Zhang Z, Xu X. Lactate clearance is a useful biomarker for the prediction of all-cause mortality in critically ill patients: a systematic review and meta-analysis. Crit Care Med. 2014;42:2118-25.
  • 15. Bernardin G, Pradier C, Tiger F, Deloffre P, Mattei M. Blood pressure and arterial lactate level are early indicators of short-term survival in human septic shock. Intensive Care Med. 1996;22:17–25.
  • 16. Nguyen HB, Rivers EP, Knoblich BP, et al. Early lactate clearance is associated with improved outcome in severe sepsis and septic shock. Critical Care Med. 2004;32:1637-42.
  • 17. Cain SM. Oxygen delivery and uptake in dogs during anemic and hypoxic hypoxia. J Appl Physiol Respir Environ Exerc Physiol. 1977;42:228-34.
There are 17 citations in total.

Details

Primary Language English
Subjects Health Care Administration
Journal Section Research article
Authors

Nazlı Görmeli Kurt 0000-0003-1757-9488

Murat Orak

Mehmet Üstündağ This is me

Publication Date May 1, 2018
Published in Issue Year 2018

Cite

APA Görmeli Kurt, N., Orak, M., & Üstündağ, M. (2018). The role of lactate clearance on deciding discharge in exacerbation of chronic obstructive pulmonary disease: Retrospective cohort study. Journal of Surgery and Medicine, 2(2), 96-98. https://doi.org/10.28982/josam.409615
AMA Görmeli Kurt N, Orak M, Üstündağ M. The role of lactate clearance on deciding discharge in exacerbation of chronic obstructive pulmonary disease: Retrospective cohort study. J Surg Med. May 2018;2(2):96-98. doi:10.28982/josam.409615
Chicago Görmeli Kurt, Nazlı, Murat Orak, and Mehmet Üstündağ. “The Role of Lactate Clearance on Deciding Discharge in Exacerbation of Chronic Obstructive Pulmonary Disease: Retrospective Cohort Study”. Journal of Surgery and Medicine 2, no. 2 (May 2018): 96-98. https://doi.org/10.28982/josam.409615.
EndNote Görmeli Kurt N, Orak M, Üstündağ M (May 1, 2018) The role of lactate clearance on deciding discharge in exacerbation of chronic obstructive pulmonary disease: Retrospective cohort study. Journal of Surgery and Medicine 2 2 96–98.
IEEE N. Görmeli Kurt, M. Orak, and M. Üstündağ, “The role of lactate clearance on deciding discharge in exacerbation of chronic obstructive pulmonary disease: Retrospective cohort study”, J Surg Med, vol. 2, no. 2, pp. 96–98, 2018, doi: 10.28982/josam.409615.
ISNAD Görmeli Kurt, Nazlı et al. “The Role of Lactate Clearance on Deciding Discharge in Exacerbation of Chronic Obstructive Pulmonary Disease: Retrospective Cohort Study”. Journal of Surgery and Medicine 2/2 (May 2018), 96-98. https://doi.org/10.28982/josam.409615.
JAMA Görmeli Kurt N, Orak M, Üstündağ M. The role of lactate clearance on deciding discharge in exacerbation of chronic obstructive pulmonary disease: Retrospective cohort study. J Surg Med. 2018;2:96–98.
MLA Görmeli Kurt, Nazlı et al. “The Role of Lactate Clearance on Deciding Discharge in Exacerbation of Chronic Obstructive Pulmonary Disease: Retrospective Cohort Study”. Journal of Surgery and Medicine, vol. 2, no. 2, 2018, pp. 96-98, doi:10.28982/josam.409615.
Vancouver Görmeli Kurt N, Orak M, Üstündağ M. The role of lactate clearance on deciding discharge in exacerbation of chronic obstructive pulmonary disease: Retrospective cohort study. J Surg Med. 2018;2(2):96-8.